A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Douglas K Rex, MD
Indiana University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of South Alabama
Mobile, Alabama, United States
- Advanced Clinical Research Institute
Anaheim, California, United States
- Precision Research Institute
Chula Vista, California, United States
- Precision Research Institute
San Diego, California, United States
- Borland-Grover Clinic, P.A
Jacksonville, Florida, United States
- Indiana University Health
Indianapolis, Indiana, United States
- Delta Research Partners Inc
Monroe, Louisiana, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Wake Research Associates
Raleigh, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Thomas Jefferson Medical College
Philadelphia, Pennsylvania, United States
- Nashville Medical Research Institute
Nashville, Tennessee, United States
- Gastroenterology Associates of Tidewater
Chesapeake, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Mar 2015
- Primary completion
- 30 Apr 2016
- Completion
- 19 Apr 2016
- Last update posted
- 20 Oct 2020
- Registered enrollment
- 461
- Registry id
- NCT02290873
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.